Humacyte, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.63
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
5
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.23
|
0.00
|
0.23
|
100.00%
|
|
2022-09-30
|
-0.21
|
-0.25
|
-0.04
|
-19.05%
|
|
2022-06-30
|
-0.22
|
0.35
|
0.57
|
259.09%
|
|
2022-03-31
|
-0.21
|
-0.19
|
0.02
|
9.52%
|
|
2021-12-31
|
-0.20
|
0.41
|
0.61
|
305.00%
|
|
2021-09-30
|
-0.20
|
-0.72
|
-0.52
|
-260.00%
|
|
2021-06-30
|
-0.56
|
-0.76
|
-0.20
|
-35.71%
|
|
2021-03-31
|
-0.90
|
-0.91
|
-0.01
|
-1.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.09
|
|
2021-12-31
|
-1.98
|
|
2020-12-31
|
-0.01
|